Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Operational Other
confidence 85%
filed 2026-08-13
EX-99.1
This announcement discloses the granting of a new U.S. composition of matter patent for ATH434 extending protection to at least 2045. While primarily an intellectual property milestone, the disclosure emphasizes material strategic and commercial value: it strengthens ATH434's long-term commercial potential, enables future development in Parkinson's disease, supports potential partnerships, and represents "one of the most critical steps" in protecting the innovation behind the company's lead clinical asset. This is a material operational/strategic event affecting the registrant's competitive position and development prospects, though it does not fit the specific categories of M&A, litigation, or regulatory approval.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-13
EX-99.1
This is a press release announcing Bullish's second quarter 2026 financial results, disclosing Q2'2026 digital asset sales of $32.6 billion, net loss of $(280.0) million, adjusted revenue of $92.6 million, and adjusted EBITDA of $29.5 million. The document explicitly states "Bullish Reports Second Quarter 2026 Results" and includes detailed financial highlights, business metrics, and refined full-year 2026 guidance. This is a material earnings disclosure that would affect a reasonable investor's assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release disclosing Creative Realities' financial results for the fiscal 2026 second quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, reports key metrics including revenue of $21.5 million (up from $13.0 million YoY), gross profit of $8.3 million, Adjusted EBITDA of $2.0 million, and ARR of $20.5 million, along with a net loss of $4.2 million. The disclosure is material as it provides investors with the company's quarterly operating performance and financial condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release disclosing Rekor Systems' Q2 2026 financial results. The 8-K Item 2.02 explicitly states the company "issued a press release summarizing the Company's financial results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly revenue ($12.7M), gross margin (56%), Adjusted EBITDA loss ($1.2M), and forward guidance toward profitability in H2 2026, along with condensed consolidated balance sheets and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including net revenues of $36.9 million, net income of $409 thousand ($0.02 per diluted share), and Adjusted EBITDA of $2.1 million. The press release (Exhibit 99.1) is attached and highlights the company's "return to profitability for the first time since the first quarter of 2025," making this material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
FitLife Brands issued a press release on August 13, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing total revenue of $26.5 million (up 65% YoY), net income of $2.0 million, and EPS of $0.21 basic and $0.20 diluted.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-13
Item 5.07
FitLife Brands held its 2026 Annual Meeting of Stockholders on August 11, 2026, with shareholders electing five directors (Dayton Judd, Grant Dawson, Matt Lingenbrink, Seth Yakatan, and Shannon Pappas) and ratifying Weinberg & Company, P.A. as independent auditors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02. The press release discloses total revenue of $7.4 million, net loss of $12.1 million ($0.54 per diluted share), and includes detailed financial statements and reconciliations to non-GAAP measures. The filing includes the full press release as Exhibit 99.1 and investor presentation as Exhibit 99.2, which are typical components of an earnings disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-13
Item 7.01
HireQuest's Board declared a quarterly cash dividend of $0.06 per share payable September 15, 2026, to shareholders of record on September 1, 2026. This is a straightforward dividend declaration disclosed via press release in Item 7.01. The event is material as it represents a capital distribution decision affecting shareholder returns and reflects the company's financial position and capital allocation strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
ImmuCell issued a press release on August 13, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes condensed statements of income, balance sheet data, and cash flow data for the period, with management commentary on revenue growth (11.5%), net income ($1.8 million), and operational performance. This is a standard quarterly earnings release attached as Exhibit 99.1, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-13
Item 8.01
The filing discloses a declaration of a cash dividend of $0.24 per common share, payable September 15, 2026, to shareholders of record on September 1, 2026. This is a routine but material dividend distribution that affects shareholder value and is typically disclosed in 8-K Item 8.01 (Other Events) filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
Item 2.02 discloses Laird Superfood's financial results for Q2 2026 via a press release (Exhibit 99.1). The press release reports quarterly revenue of $41.3 million (244% increase YoY), net loss of $1.8 million, and adjusted EBITDA of $3.0 million, along with detailed segment and channel performance metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release (Exhibit 99.1) discloses comprehensive financial results including record revenue of $37.6 million (99% YoY growth), net income of $11.6 million ($0.35 per diluted share), and raised full-year 2026 revenue guidance to exceed $145 million. The disclosure is material to investors as it demonstrates strong operational performance and includes forward-looking guidance adjustments.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-08-13
Item 2.02
BK Technologies Corporation disclosed its financial and operating results for the second quarter ended June 30, 2026, through an amended press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2) furnished under Items 2.02 and 7.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-08-13
Item 1.01
Dominari Holdings entered into inducement agreements with warrant holders on August 13, 2026, offering either cash exercise at a reduced price ($2.20 vs. $3.72) or a 5:1 warrant-for-stock exchange. This represents a material capital restructuring involving the issuance of approximately 115,000 shares and expected gross proceeds of $2.9 million, reducing outstanding warrants from 3.1 million to 1.2 million. While technically a warrant modification rather than a traditional M&A transaction, the scale and nature of the transaction—involving material equity issuance and cash proceeds—fits the ma_activity category as a material definitive agreement affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-13
Item 5.02
Mr. David B. Snow, Jr., a director since 2014, notified the Company of his intention to retire from the Board effective September 30, 2026. The disclosure centers on the departure of a board member, with no appointment of a replacement or compensation arrangement disclosed. The retirement is attributed to personal reasons with no disagreement noted.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses second quarter 2026 financial results for 22nd Century Group via Item 2.02, with an earnings release furnished as Exhibit 99.1. The release reports Q2 2026 revenues of $2.9 million (down 29.9% YoY), net loss of $3.3 million, and cash position of $6.1 million, along with operational updates on VLN® product commercialization. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and cash runway.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
The 8-K discloses AIRO's second quarter 2026 financial results via Item 2.02, with a press release attached as Exhibit 99.1. The filing reports Q2 2026 revenue of $43.2 million (76% YoY growth), gross margin of 64%, operating income of $1.7 million, and net loss of $(2) million, along with full-year 2026 revenue guidance of 15-25% growth. This is a standard quarterly earnings release material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-13
EX-99.5
This is a press release announcing Kolibri Global Energy's Q2 2026 financial results, disclosing record quarterly revenue of $22.5 million (109% increase YoY), net income of $8.5 million (197% increase YoY), and production growth of 46%. The document contains condensed consolidated financial statements, detailed operational metrics, and management commentary on results—all hallmarks of an earnings release. Filed as Exhibit 99.5 to a 6-K on August 13, 2026, it discloses material financial performance that would affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-13
The filing discloses Q2 2026 financial results via press release (Item 2.02), including condensed consolidated balance sheets, statements of operations, and cash flows for the six months ended June 30, 2026. While the filing also contains shareholder vote results (Item 5.07), the primary substantive disclosure is the earnings announcement with detailed financial statements showing a net loss of $4.3 million for the six months and cash position of $11.6 million as of June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses Abeona Therapeutics' financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release reports net ZEVASKYN revenue of $11.4 million (31% quarter-over-quarter growth), net loss of $(20.2) million, and cash position of $146.8 million as of June 30, 2026, along with condensed consolidated financial statements. This is a standard quarterly earnings disclosure material to investors assessing the company's commercial progress and financial condition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-13
The filing discloses a material acquisition in progress: HCWC entered into an Agreement and Plan of Merger on May 27, 2026 to acquire Host Digital Infrastructure LLC, with a definitive proxy statement filed on August 6, 2026. The current 8-K (Item 8.01) announces a major commercial milestone—Host Digital's execution of a 15-year, $1.25 billion base-term lease (potentially $3.2 billion over 30 years) with a major cloud infrastructure company, which materially enhances the value and strategic importance of the pending acquisition. This is a material event in the context of the ongoing merger transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses second-quarter 2026 and half-year financial and operating results via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes condensed consolidated balance sheets, statements of operations, and detailed financial highlights showing total assets increased 38% to $511.8 million and total revenue increased 7% year-over-year to $8.5 million for the six-month period. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-13
EX-99.1
This is a press release announcing unaudited financial results for the six months ended March 31, 2026. The exhibit discloses revenue of $5.93 million (13.9% growth), gross profit of $1.76 million (20.9% growth), and a net loss of $1.90 million (versus prior-year net income of $0.91 million), along with complete condensed consolidated financial statements. The shift from profitability to loss, driven by significant game enhancement costs ($2.13 million) and professional service fees, is material to investor assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-13
The 8-K discloses Pulmatrix's second quarter 2026 financial results via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated balance sheets and statements of operations for the periods ended June 30, 2026, along with a corporate update regarding the pending merger with Eos SENOLYTIX. While the filing also discusses M&A activity, the primary disclosure mechanism and Item cited is the earnings release itself, making this the most salient event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses financial results for Q2 2026 (ended June 30, 2026) via a press release attached as Exhibit 99.1, filed under Item 2.02 (Results of Operations and Financial Condition). The press release reports $1.5 million in revenue, 2,770 tests processed, a net loss of $14.7 million, and cash position of $33.4 million, along with business highlights including a new laboratory benefit manager coverage policy. This is a standard quarterly earnings release disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-13
The filing discloses the August 12, 2026 closing of a convertible note offering under a securities purchase agreement originally entered June 27, 2025. The Company issued the August 2026 Note in the principal amount of $1,099,989.00 with a 10% original issue discount and 10% annual interest, maturing August 12, 2027, along with warrants to purchase 112,531 shares. This represents a material creation of a direct financial obligation through debt issuance, even though the notes are convertible into equity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses financial results for Q2 and six months ended June 30, 2026 via Item 2.02 (Results of Operations and Financial Condition). The press release (Exhibit 99.1) reports revenues of $321,000 (Q2) and $554,000 (six months), net losses of $2.0 million (Q2) and $4.0 million (six months), and includes detailed consolidated balance sheets and statements of operations. This is a standard earnings release disclosure with full financial statements attached.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-13
Tron Inc. announced a major strategic initiative to pursue election as a Super Representative (SR) for the TRON network and deepen integration with the TRON DAO ecosystem. This is a material operational and strategic business development—the company plans to participate directly in block production and on-chain governance to generate recurring revenue. While the filing is disclosed via Item 7.01 (Regulation FD Disclosure) rather than a dedicated Item, the substance is a significant strategic pivot that would affect a reasonable investor's assessment of the company's business direction and revenue prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses Cingulate's financial results for Q2 2026 (quarter ended June 30, 2026) via Item 2.02 and an attached press release (Exhibit 99.1). The press release reports Q2 and H1 2026 financial results including cash position ($28.4M), R&D expenses ($1.5M for Q2), SG&A expenses ($3.9M for Q2), and net loss ($5.9M for Q2), along with a business update on CTx-1301 regulatory progress and commercial readiness. This is a standard earnings release disclosure material to investors assessing the company's financial condition and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses Co-Diagnostics' financial results for Q2 2026 (quarter ended June 30, 2026) via a press release dated August 13, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release presents revenue ($0.17M), operating loss ($6.2M), net loss ($6.3M or $1.46 per share), and adjusted EBITDA loss ($5.8M), along with business highlights and recent developments. This is a standard quarterly earnings disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The filing discloses Q2 2026 financial results via Item 2.02 and an attached press release (Exhibit 99.1). The press release announces quarterly revenue of $2.6 million (up 57% YoY), net loss of $4.0 million (narrowed from Q1), and Adjusted EBITDA loss of $2.6 million. This is a standard earnings release for a public company's quarterly results, material to investors assessing operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release dated August 13, 2026 reporting record Q2 2026 revenue of approximately $4.5 million and providing forward guidance for Q4 revenue of $6-7 million. The press release highlights major customer wins, production scaling, and margin expansion expectations, which are material to investors assessing the company's financial trajectory and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
The 8-K discloses third quarter fiscal year 2026 financial results for NANO Nuclear Energy Inc. via a press release filed as Exhibit 99.1. Item 8.01 explicitly states the company "issued a press release reporting its third quarter fiscal year 2026 financial results and providing a business update." The press release includes cash position ($580 million), operating activities ($18.7 million used), investing activities ($297.6 million used), and financing activities ($411.5 million provided), along with key operational achievements including NRC acceptance of a Construction Permit Application and the STS acquisition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-13
The filing discloses entry into two material stock purchase agreements on August 7, 2026: (1) acquisition of 60% of Xing Da Plastics Sdn. Bhd. for 4.8 million shares of common stock, and (2) acquisition of 100% of Invent Fortune for 21.9 million shares of common stock. These are material acquisitions under Item 1.01, involving substantial equity consideration and representing significant business combinations that would materially affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
NextBoat Inc. disclosed its fiscal second quarter 2026 financial results via press release dated August 13, 2026, filed under Item 7.01 (Regulation FD Disclosure). The filing reports record revenue of $59.1 million (88.4% YoY increase), record units transacted (138% YoY increase), and gross profit of $9.5 million (100.1% YoY increase), along with condensed consolidated financial statements for the three and six months ended June 30, 2026. This is a standard quarterly earnings release material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-13
The filing discloses execution of a definitive agreement to acquire Special Project Delivery, Inc. (SPD) in an all-stock transaction for up to 4.8 million shares, expected to close before end of 2026 subject to stockholder approval. This is a material acquisition that expands Mobix's national security platform into rare earth elements and critical minerals. The press release (Exhibit 99.1) emphasizes this as "transformational" and a "cornerstone" of the company's strategic direction, clearly meeting the materiality threshold for M&A activity under Item 1.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-13
Liberty Star Uranium & Metals Corp. entered into a Securities Purchase Agreement on August 11, 2026, to issue a convertible promissory note with a principal amount of $73,700 bearing 8% interest and maturing May 30, 2027. This is a creation of a direct financial obligation disclosed under Items 1.01 and 2.03, constituting a debt issuance. The convertible feature does not change the primary classification—the core event is the creation of a new debt obligation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-13
The 8-K discloses second quarter 2026 financial results via a press release dated August 12, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The press release includes consolidated statements of operations and balance sheet data for the three months ended June 30, 2026, showing net loss of $0.4 million and key operational metrics. While the filing also mentions a material business combination agreement with Future NRG and a securities purchase agreement, the primary disclosure vehicle and Item designation center on the earnings release itself.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-13
Item 5.02
Scott Scheirman was appointed to Oportun's Board of Directors effective August 11, 2026, as a Class I director and Chair of the Audit & Risk Committee, bringing extensive executive and board experience from major financial services companies including prior CEO and CFO roles.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-13
Item 5.07
Results of the 2026 Annual Meeting of stockholders were disclosed, with all four proposals passing: election of Mohit Daswani as a Class I director, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-13
Item 8.01
News Corporation disclosed daily buy-back notifications under its $1 billion repurchase program authorized July 15, 2025, reporting purchases of approximately 10.7 million Class A shares and 62,323 Class B shares on August 13, 2026, for a total consideration of approximately $276.1 million. Share repurchase programs are a form of capital return to shareholders and fall within the dividend_distribution taxonomy as a return of capital mechanism, distinct from operational or financial events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-13
Item 7.01
Liberty Global disclosed the financial report of its wholly-owned subsidiary VodafoneZiggo for Q2 2026 (quarter ended June 30, 2026) made available on August 13, 2026. Although filed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is a quarterly earnings release for a material operating subsidiary. The disclosure of quarterly financial results for a significant subsidiary would affect a reasonable investor's assessment of the parent company's financial condition and performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-13
Item 2.02
This is a standard quarterly earnings release for Q2 2026 filed under Item 2.02. The press release (Exhibit 99.1) discloses financial results including R&D expense ($6.8M), G&A expense ($3.6M), net loss ($8.2M), net loss per share ($0.43), and cash position ($23.5M as of June 30, 2026), along with corporate updates on clinical trials and financing activities. The disclosure is material as it provides investors with the company's financial performance and operational progress for the quarter.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
This is a straightforward quarterly earnings release for Q2 2026 (three and six months ended June 30, 2026). The press release discloses net sales of $17.8 million (11% increase YoY), gross profit of $3.2 million (30% increase YoY), net loss of $1.2 million (improved from $1.5 million loss in prior year), and cash position of $24.8 million. The filing includes full financial statements and forward guidance for 2026. This is a material disclosure affecting investor assessment of the company's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-13
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended July 4, 2026) filed under Item 2.02 Results of Operations and Financial Condition. The 8-K incorporates by reference a press release (Exhibit 99.1) announcing second quarter financial results including revenue of $506.4 million, diluted EPS of $0.37, and an updated full-year 2026 outlook with raised guidance. The disclosure includes detailed financial statements, segment performance, and management commentary from CEO Chris Hufnagel.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
Alliance Laundry issued a press release on August 13, 2026 disclosing second quarter 2026 financial results, including net revenue of $477 million (up 7%), net income of $69 million (up 121%), and Adjusted EBITDA of $134 million (up 12%), along with updated full-year 2026 guidance raising Adjusted EBITDA growth to +8% to 10%. This is a standard quarterly earnings release attached as Exhibit 99.1 to Item 2.02, which is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 97%
filed 2026-08-13
EX-99.1
Stratasys disclosed Q2 2026 financial results via press release and earnings presentation, reporting revenue of $137.6 million, GAAP net loss of $16.9 million, and non-GAAP net income of $2.3 million, along with updated full-year 2026 guidance of $565–$575 million in revenue.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-13
Item 2.02
ADI Global Distribution Inc. announced second quarter 2026 financial results, reporting record net revenue of $1,286 million, net income of $6 million, and Adjusted EBITDA of $86 million, along with full-year 2026 guidance.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-08-13
This 6-K furnishes unaudited condensed consolidated financial statements for the six-month period ended June 30, 2026, including statements of income, comprehensive income, balance sheet, cash flows, and changes in equity. The document explicitly states it contains "Unaudited Condensed Consolidated Financial Statements as of June 30, 2026 and December 31, 2025 and for the six-month period ended June 30, 2026 and 2025," which is a periodic interim (half-year) financial report, not a discrete event or earnings release announcement.
View raw filing on EDGAR →